MACC1 induces metastasis in ovarian carcinoma by upregulating hepatocyte growth factor receptor c-MET

Oncology Letters

Volumn 8, Issue 2, 2014, Pages 891-897

  Sheng, Xiu Jie ^a   Li, Zhen ^a   Sun, Man ^a   Wang, Zhi Hui ^a   Zhou, Dong Mei ^a   Li, Jian Qi ^a   Zhao, Qin ^a   Sun, Xiao Fang ^b   Liu, Qi Cai ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

^b Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institutes   (China)

Author keywords

c MET; Metastasis; Metastasis associated in colon cancer 1; Ovarian carcinoma

Indexed keywords

MESSENGER RNA; SCATTER FACTOR RECEPTOR; SMALL INTERFERING RNA;

ANGIOGENESIS; ARTICLE; ASSAY; CELL ADHESION ASSAY; CELL INVASION; CELL MIGRATION; CELL MIGRATION ASSAY; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE; HUMAN; HUMAN CELL; MATRIGEL INVASION ASSAY; METASTASIS; METASTASIS ASSOCIATED IN COLON CANCER 1 GENE; OVARY CARCINOMA; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; RNA INTERFERENCE; TUBE FORMATION ASSAY; UPREGULATION; WESTERN BLOTTING; WOUND HEALING ASSAY;

EID: 84902320321     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2184     Document Type: Article

References (23)

1. Siegel R, Ward E, Brawley O and Jemal A: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 61: 212-236, 2011.
2. Chen J, Liu X, Zhang J and Zhao Y: Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference. J Cell Physiol 227: 3629-3638, 2012.
3. Stein U, Walther W, Arlt F, et al: MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis. Nat Med 15: 59-67, 2009.
4. Shirahata A, Shinmura K, Kitamura Y, et al: MACC1 as a marker for advanced colorectal carcinoma. Anticancer Res 30: 2689-2692, 2010.
5. Qiu J, Huang P, Liu Q, et al: Identification of MACC1 as a novel prognostic marker in hepatocellular carcinoma. J Transl Med 9: 166, 2011.
6. Chundong G, Uramoto H, Onitsuka T, et al: Molecular diagnosis of MACC1 status in lung adenocarcinoma by immunohistochemical analysis. Anticancer Res 31: 1141-1145, 2011.
7. Tachibana K, Minami Y, Shiba-Ishii A, et al: Abnormality of the hepatocyte growth factor/MET pathway in pulmonary adenocarcinogenesis. Lung Cancer 75: 181-188, 2012.
8. You WK and McDonald DM: The hepatocyte growth factor/c-Met signaling pathway as a therapeutic target to inhibit angiogenesis. BMB Rep 41: 833-839, 2008.
9. Stein U, Dahlmann M and Walther W: MACC1-more than metastasis? Facts and predictions about a novel gene. J Mol Med 88: 11-18, 2010.
10. Qin X, Yan L, Zhao X, Li C and Fu Y: microRNA-21 overexpression contributes to cell proliferation by targeting PTEN in endometrioid endometrial cancer. Oncol Lett 4: 1290-1296. 2012.
11. Ye Q, Yan Z, Liao X, et al: MUC1 induces metastasis in esophageal squamous cell carcinoma by upregulating matrix metalloproteinase 13. Lab Invest 91: 778-787, 2011.
12. Wu ZS, Wang CQ, Xiang R, et al: Loss of miR-133a expression associated with poor survival of breast cancer and restoration of miR-133a expression inhibited breast cancer cell growth and invasion. BMC Cancer 12: 51, 2012.
13. Shimokawa H, Uramoto H, Onitsuka T, et al: Overexpression of MACC1 mRNA in lung adenocarcinoma is associated with postoperative recurrence. J Thorac Cardiovasc Surg 141: 895-898, 2011.
14. Shirahata A, Fan W, Sakuraba K, et al: MACC 1 as a marker for vascular invasive hepatocellular carcinoma. Anticancer Res 31: 777-780, 2011.
15. Shirahata A, Sakata M, Kitamura Y, et al: MACC 1 as a marker for peritoneal-disseminated gastric carcinoma. Anticancer Res 30: 3441-3444, 2010.
16. Zhang RT, Shi HR, Huang HL, et al: Expressions of MACC1, HGF, and C-met protein in epithelial ovarian cancer and their significance. Nan Fang Yi Ke Da Xue Xue Bao 31: 1551-1555, 2011 (In Chinese).
17. Zhang R, Shi H, Chen Z, et al: Effects of metastasis-associated in colon cancer 1 inhibition by small hairpin RNA on ovarian carcinoma OVCAR-3 cells. J Exp Clin Cancer Res 30: 83-107, 2011.
18. Chen XQ, Yang S, Kang MQ, et al: Survivin expression in human lung cancer and the influence of its downregulation on the biological behavior of human lung cancer cells. Exp Ther Med 3: 1010-1014, 2012.
19. Liu Y: The human hepatocyte growth factor receptor gene: complete structural organization and promoter characterization. Gene 215: 159-169, 1998.
20. Mitra AK, Sawada K, Tiwari P, et al: Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis. Oncogene 30: 1566-1576, 2011.
21. Bu R, Uddin S, Bavi P, et al: HGF/c-Met pathway has a prominent role in mediating antiapoptotic signals through AKT in epithelial ovarian carcinoma. Lab Invest 91: 124-137, 2011.
22. Seiden-Long IM, Brown KR, Shih W, et al: Transcriptional targets of hepatocyte growth factor signaling and Ki-ras oncogene activation in colorectal cancer. Oncogene 25: 91-102, 2006.
23. You H, Ding W, Dang H, Jiang Y, Rountree CB: c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma. Hepatology 54: 879-889, 2011.